Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KMT2C | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | HES6 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | CAST | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | FAM221A | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | SHC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | RCOR3 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |